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the expense of radiation-induced late toxicity. Progressive 
cell depletion and inflammation are the leading mechanisms 
of acute toxicity which is observed during or shortly after 
treatment. The pathogenetic pathways of late toxicity, 
developing 90 days or later after the onset of radiotherapy, 
are more complex and involve processes such as vascular 
sclerosis and fibrosis. Since many patients have become long-
term survivors, awareness and recognition of radiation-
related toxicity has gained in importance and increased 
efforts are made for its prevention and management.  
Technical innovations contribute to a reduction in 
radiotherapy-associated toxicity. The steep dose gradients of 
highly-conformal radiotherapy techniques allow for an 
accurate dose delivery with optimal sparing of the normal 
tissues. Several studies have demonstrated the dosimetrical 
benefit of intensity-modulated radiotherapy (IMRT) and 
volumetric modulated arc radiotherapy (VMAT) compared to 
conventional radiotherapy techniques. It has been shown that 
the dosimetrical benefit of IMRT translated into a clinically 
significant reduction in lower gastrointestinal toxicity 
compared with three-field conventional radiotherapy. In the 
near future MRI-linacs and proton therapy are likely to 
broaden the therapeutic window further. Prone positioning 
on a bellyboard reduces small bowel toxicity by pushing away 
the small bowel loops from the high dose region. Image-
guided radiotherapy allows for an accurate definition, 
localization and monitoring of tumor position, size and shape 
before and during treatment and may help to reduce set-up 
margins.  
Small randomized controlled trials have shown that the 
administration of several agents might have a beneficial 
effect for the prevention of acute (e.g. intrarectal 
amifostine, oral sulfasalazine and balsalazide) and/or late-
onset radiation-induced toxicity (intrarectal beclomethasone 
and oral probiotics). Once severe toxicity develops, total 
replacement of the diet with elemental formula may be 
appropriate. Probiotics influence the bacterial microflora and 
seem promising in reducing the incidence and severity of 
radiation-induced diarrhea. Currently there is insufficient 
evidence for cytoprotective and anti-inflammatory drugs in 
the management of radiation-induced toxicity. Future 
challenges lie in the prediction of treatment-related toxicity, 
which might be a promising step towards an individualized 
risk-adapted treatment. 
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As the cure rates for childhood cancers continue to improve 
with better local control and outcome, the incidence and 
management of long-term consequences are a constant 
challenge. Conservative treatments include a combination of 
chemotherapy, radiotherapy and surgery that may lead to 5 
year-survival rates > 90%. The use of brachytherapy, 
whenever feasible, is an attractive alternative when ionizing 
radiation is needed for the treatment of paediatric cancers, 
especially rhabdomyosarcomas (RMS). In genital RMS, 
brachytherapy represents an alternative to radical surgery: 
hysterectomy or colpectomy in girls and cysto-prostatectomy 
in boys. When brachytherapy is properly applied, the 
probability of late complications remains low with a high 
cure-rate. At Gustave Roussy Hospital, since decades, 
brachytherapy –when possible– has been proposed as an 
alternative to external irradiation or radical surgery. So far, 
more than 150 children have been treated with 
brachytherapy, in the context of multidisciplinary approach, 
including chemotherapy +/- conservative surgery. The most 
frequent tumour sites were vagina/uterine cervix, 
bladder/prostate and nasolabial fold, the most common 
histopathological type being RMS. In a series of 39 girls 
treated between 1971 and 2005, interstitial brachytherapy 
was used for vulval tumors, and endocavitary brachytherapy 
was used in vaginal tumours with individually tailored 
moulded vaginal applicators. Among them, 20 patients were 
treated before 1990, where the initial tumoral extension was 
included in the brachytherapy volume, while after 1990, only 
residual disease after initial chemotherapy was treated. The 
usual prescribed dose was 60-65 Gy delivered in one to three 
brachytherapy applications, taking into account the doses to 
organs at risk. With a median follow of 8.4 years, local 
recurrence was reported in 2 patients (5.1%) in the first year 
following the treatment, regional relapse in 1 patient (2.6%) 
and distant recurrences in 7 patients (17.9%). Among the 20 
patients treated before 1990, 15 presented long-term 
sequelae, (vaginal or urethral sclerosis or stenosis) with three 
requiring surgical treatment. By contrast, among the 19 
patients treated after 1990, four patients had vaginal or 
urethral stenosis, none of them requiring surgery. A recent 
long-term toxicity analysis confirmed the increase of the 
total number of G3-4 late effects in patients treated before 
1990. From 1991 to 2007, 26 boys with bladder/prostate RMS 
were treated with brachytherapy as a perioperative 
procedure. All of them underwent a conservative surgical 
procedure, with bladder-neck and urethra preservation. 
Brachytherapy was systematically performed after tumor 
resection, consisting of two loops encompassing the prostate 
and the bladder-neck area. A total dose of 60 Gy was 
delivered with low dose rate. With a median follow-up of 4 
years (10 months-14.5 years), only one patient locally 
relapsed out of the brachytherapy treated area. Among 11 
boys older than 6 years, 9 (82%) were normally continent, 
two had diurnal dribbling treated by bladder education. 
Recently, sexual and urinary functions, assessed with a 
quality of life (QoL) questionnaire, were studied in a cohort 
of 22 long-term survivors. The results showed that the great 
majority of long terms surviving males (76%) considered 
themselves as having normal QoL. Between 1971 and 2005, 16 
children with RMS of the nasolabial fold were treated with 
brachytherapy. Ten presented embryonal RMS and six 
alveolar RMS. In 12 cases, brachytherapy was combined with 
local excision. The doses ranged from 50 to 70 Gy, depending 
on chemotherapy response, and surgical margins. With a 
median follow-up of 4.4 years (1.7–33), 10 patients relapsed: 
4 local, 6 regional, and 2 metastatic failures were reported. 
In this particular context, brachytherapy provided an 
acceptable local control rate, but with a poor regional 
control. The ballistic interest of BT has been clearly 
demonstrated in paediatric RMS, with a very high dose 
gradient, sparing normal tissue and very high tumor dose. In 
our experience low dose-rate brachytherapy was used and 
recently had to move to pulsed dose-rate brachytherapy. 
Such conservative approach, minimizing late sequelae 
without detrimental effect on local control, should be 
offered whenever possible. This treatment is a clear 
demonstration of the multidisciplinary team approach, 
including surgeons, pediatricians and radiation oncologists. 
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Radiotherapy has relied on computed tomography (CT) for 
both target definition and treatment planning during the last 
decades. However, the increasing accuracy in radiation 
delivery, through highly conformal techniques such as 
intensity modulated radiotherapy (IMRT) and image guided 
